Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
Naunyn Schmiedebergs Arch Pharmacol ; 391(12): 1387-1397, 2018 12.
Article in English | MEDLINE | ID: mdl-30145688

ABSTRACT

The anti-inflammatory effects of histamine H4 receptor (H4R) antagonists opened new therapeutic options for the treatment of inflammatory/allergic diseases, but the role of H4R in inflammation is far from being solved. Aim of the present study was to investigate the role of structurally related H4R ligands of the aminopyrimidine class with different efficacies and functionalities (neutral antagonist ST-994, partial agonist ST-1006, inverse agonist ST-1012, and partial inverse agonist ST-1124) on croton oil-induced ear edema and pruritus in mice. The H4R ligands were administered subcutaneously before topical application of croton oil. While ST-1006 and ST-1124 were ineffective at any dose tested (10-100 mg/kg), both ST-994 and ST-1012 (30 and 100 mg/kg) significantly reduced croton oil-induced ear edema. Moreover, ST-994, ST-1006, and ST-1124, but not ST-1012, significantly inhibited croton oil-induced ear pruritus at 30 mg/kg. In accordance with results obtained with the reference H4R antagonist JNJ7777120 (100 mg/kg), histological examination of inflamed ear tissue indicated that treatment with ST-994 (30 mg/kg) led to a significant reduction in the inflammatory severity score and in the number of eosinophils infiltrating the tissue, while the number of degranulated mast cells in inflamed tissues was increased in comparison with the number of intact mast cells. These data indicate that croton oil-induced ear inflammation and pruritus seem to be clearly, but variably, affected by the H4R ligands tested. The potential advantage of dual effect of the H4R neutral antagonist ST-994 has to be carefully considered as a new therapeutic approach to the treatment of inflammatory diseases.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Dermatitis, Irritant/drug therapy , Pruritus/drug therapy , Pyrimidines/therapeutic use , Receptors, Histamine H4/metabolism , Acute Disease , Animals , Croton Oil , Dermatitis, Irritant/pathology , Ear/pathology , Ligands , Male , Mice , Pruritus/chemically induced , Pruritus/pathology
2.
Tissue Cell ; 47(2): 147-51, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25697061

ABSTRACT

Nociceptin/orphanin FQ (N/OFQ), the endogenous ligand of the N/OFQ peptide (NOP) receptor, is a neuropeptide regulating gastrointestinal functions. The present study investigated the influence of acute cold-restraint stress and of short- and long-lasting peripheral infusion of N/OFQ on the level of synaptophysin, an exocytotic protein involved in neural plasticity. Exposure to cold-restraint stress for 3h or subcutaneous infusion of N/OFQ, 1 µg/kg/h for 4h, induced a significant increase of the area of synaptophysin-immunoreactive nerve fibers in the fundic mucosa, while prolonged subcutaneous infusion of N/OFQ, 1 µg/kg/h for 52 h and for 14 days, did not modify the synaptophysin-immunostained fibers. In the colonic mucosa stress exposure and subcutaneous infusion of N/OFQ, at any time point considered, had no significant effect on the area of synaptophysin-immunoreactive nerve fibers. Synaptophysin immunoreactive nerve fibers were decreased in knockout rats for the NOP receptor gene both in the fundic and colonic mucosa. Synaptophysin-immunoreactivity was demonstrated in cells located in the basal portion of the fundic mucosa. Our study is the first to show that the N/OFQ/NOP receptor system influences the expression of synaptophysin and hence the process of exocytosis both in nerve terminals and in cells.


Subject(s)
Intestinal Mucosa/metabolism , Stress, Physiological/physiology , Synaptophysin/metabolism , Vasodilator Agents/metabolism , Animals , Exocytosis/physiology , Male , Opioid Peptides/metabolism , Rats, Wistar , Receptors, Opioid/metabolism , Nociceptin Receptor , Nociceptin
3.
Exp Dermatol ; 21(1): 32-7, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22151388

ABSTRACT

The effects of the histamine H(4) receptor antagonist JNJ7777120 were evaluated in a model of acute skin inflammation induced by local application of croton oil. The influence of strain on the effect of JNJ7777120 was investigated in four different mouse strains (CD-1, NMRI, BALB/c and C57BL/6J). In CD-1 mice, JNJ777720 (30-100 mg/kg subcutaneously, s.c.) exerted a dose-dependent inhibition of croton oil-induced ear inflammation and polymorphonuclear leucocyte infiltration, as confirmed by histological evaluation of ear tissues. JNJ7777120 (30-100 mg/kg) did not reduce ear oedema in NMRI, BALB/c or C57BL/6J mice. The positive control, dexamethasone (2 mg/kg s.c.) induced significant anti-inflammatory effects only in CD-1 and NMRI mice. In these strains, also the histamine H(1) -receptor blocker pyrilamine (30 mg/kg s.c.) significantly reduced ear oedema at 2 h after croton oil challenge, being as effective as JNJ7777120 in CD-1 mice. Taken together, these data demonstrate that the H(4) receptor antagonist JNJ7777120 may reduce acute croton oil-induced skin inflammation as effectively as H(1) receptor blockade. However, present experiments evidenced for the first time marked strain-related differences in the JNJ7777120 pharmacological activity, which have to be carefully considered when using this ligand to characterize histamine H(4) receptor functions in murine models and translating preclinical data to clinical human settings.


Subject(s)
Dermatitis/drug therapy , Indoles/therapeutic use , Piperazines/therapeutic use , Receptors, G-Protein-Coupled/antagonists & inhibitors , Animals , Anti-Inflammatory Agents/therapeutic use , Croton Oil , Dermatitis/pathology , Dermatologic Agents , Dexamethasone/therapeutic use , Disease Models, Animal , Drug Evaluation, Preclinical , Ear, External/pathology , Histamine H1 Antagonists/therapeutic use , Indoles/pharmacology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Piperazines/pharmacology , Pyrilamine/therapeutic use , Receptors, Histamine , Receptors, Histamine H4
4.
Life Sci ; 89(19-20): 735-40, 2011 Nov 07.
Article in English | MEDLINE | ID: mdl-21925513

ABSTRACT

AIMS: Mucosal mast cells (MMC) are mediators of the stress responses in the gastrointestinal tract. We examined the effect of acute cold-restraint stress and of the neuropeptide nociceptin/orphanin FQ (N/OFQ), implicated in the modulation of stress responses, on MMC density in the rat colon. MAIN METHODS: Stress was induced by restraining the animals into individual cages at 3°C for 3h. N/OFQ and the selective N/OFQ peptide (NOP) receptor antagonist, UFP-101, were infused subcutaneously via Alzet osmotic minipumps. Segments of the distal colon were collected. MMCs were identified immunohistochemically with a monoclonal antibody to rat mast cell protease (RMCP) II and with a rabbit polyclonal antibody to CD117/c-kit receptor. KEY FINDINGS: Acute stress caused a decrease in the density of MMCs in the rat colonic mucosa. Short-term peripheral infusion of N/OFQ (0.1 to 10 µg/kg/h for 4h) caused a dose-related reduction of MMC density. Peak reduction occurred after the 4-h infusion of N/OFQ, 1 µg/kg/h. Reduction was maintained after the 52-h infusion period and declined following 7 and 14 days of infusion. The infusion of N/OFQ (1µg/kg/h for 4h) in rats exposed to acute stress caused a decrease in MMC density comparable to that obtained with the single treatments. UFP-101, at the doses of 1 and 10 µg/kg/h, which itself had no significant effect on MMC density, when concurrently infused in stress-exposed rats, abolished the stress-induced decrease of MMC density. SIGNIFICANCE: Present results indicate that the peripheral N/OFQ-NOP system is involved in stress-induced reduction of MMC density.


Subject(s)
Intestinal Mucosa/metabolism , Mast Cells/metabolism , Opioid Peptides/pharmacology , Receptors, Opioid/metabolism , Stress, Psychological/physiopathology , Animals , Colon/metabolism , Disease Models, Animal , Dose-Response Relationship, Drug , Male , Opioid Peptides/administration & dosage , Rabbits , Rats , Rats, Wistar , Time Factors , Nociceptin Receptor , Nociceptin
5.
Peptides ; 32(4): 729-36, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21262303

ABSTRACT

The endogenous neuropeptide nociceptin/orphanin FQ (N/OFQ) modulates behavioral and gastrointestinal responses to stress. Mucosal mast cells (MMCs) are primary mediators of stress-related responses in the gastrointestinal tract. We investigated the influence of N/OFQ and of the N/OFQ peptide (NOP) receptor antagonist, UFP-101, on MMCs in the rat gastric fundus. N/OFQ was infused subcutaneously for 52 h at 0.1, 1 and 10 µg/kg/h and at 1 µg/kg/h for 4h, 52 h, 7 days and 14 days via Alzet osmotic minipumps. Density of MMCs and connective tissue mast cells (CTMCs) was assessed histochemically and immunohistochemically. Activation and location of MMCs were assessed by transmission electron microscopy. Contacts between MMCs and nerve elements were assessed by double immunofluorescence. N/OFQ (1 µg/kg/h) and UFP-101 (10 and 30 µg/kg/h) were infused subcutaneously in the absence and presence of acute cold-restraint stress and density of MMCs was assessed. Peripheral N/OFQ dose-dependently increased the density of MMCs, while not influencing CTMCs. The increasing effect was maintained up to 14 days following continuous infusion, while after termination of the 4-h infusion, the effect declined rapidly. The peptide promoted the activation of MMCs and their migration from the lamina propria toward the epithelial layer. The association between MMCs and nerve fibers was time-dependently down-regulated following N/OFQ infusion. The stress-induced hyperplasia of MMCs was not influenced by N/OFQ and abolished by UFP-101. UFP-101 alone was ineffective. The present results suggest that endogenous N/OFQ could be considered a potential component of the circuit neuropeptides-mast cells-stress.


Subject(s)
Gastric Fundus/pathology , Gastric Mucosa/pathology , Hyperplasia/chemically induced , Opioid Peptides/administration & dosage , Animals , Immunohistochemistry , Male , Microscopy, Electron, Transmission , Rats , Rats, Wistar , Nociceptin
6.
Curr Protoc Toxicol ; Chapter 21: Unit 21.2, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20967744

ABSTRACT

The maintenance of gastric mucosal integrity is ensured by a dynamic balance between protective and noxious factors. The gastric mucosa has multiple protective mechanisms that allow the mucosa to withstand frequent exposure to potentially damaging agents such as acid and peptic secretions, bacterial products, ingested food, alcoholic beverages, and certain drugs. The imbalance between defensive and aggressive factors is at the basis of the formation of erosions/lesions or ulcerations of the gastric mucosa. The difference between an erosion/lesion and ulceration is that the former is confined to the mucosa, while an ulceration penetrates to the muscularis mucosae. This unit presents two models of acute mucosal lesions induced in the rat by gastrotoxic agents acting through different mechanisms of action. The protocols explain how to measure gastric mucosal lesions by microscopic examination of the stomach by light microscopy and by scanning electron microscopy.


Subject(s)
Gastric Mucosa/pathology , Stomach Diseases/pathology , Animals , Anti-Inflammatory Agents, Non-Steroidal/toxicity , Disease Models, Animal , Gastric Mucosa/drug effects , Gastric Mucosa/ultrastructure , Microscopy, Electron, Scanning , Mucous Membrane/drug effects , Mucous Membrane/pathology , Rats , Severity of Illness Index , Stomach Diseases/chemically induced , Stomach Ulcer/chemically induced , Stomach Ulcer/pathology , Toxicology/methods
7.
Pharmacology ; 85(3): 146-52, 2010.
Article in English | MEDLINE | ID: mdl-20145426

ABSTRACT

The effect of a chronic (4 weeks) administration of sulphurous thermal water on gastric acid secretion and mucosal defense was investigated in rats. Animals were randomized to receive daily intake of tap water or of thermal water obtained from a local spa center (Tabiano, Parma, Italy). Rats were followed for one month as for water and food consumption, body weight and general conditions. At the end of the watering period, the following study protocols were carried out: (a) study of basal and stimulated gastric acid secretion under general anesthesia, and (b) study of the gastric mucosal resistance against the damage induced by ethanol and indomethacin in conscious rats. Basal acid secretion and the acid response to pentagastrin or to histamine were similar in rats assuming ordinary drinking water or thermal water. As for resistance to gastric damage, histological, but not macroscopic, evaluation revealed that rats which assumed thermal water were slightly more resistant to the gastrolesive effect of ethanol (either absolute or diluted). Again, when indomethacin was used as a noxious stimulus, no difference was noted between the two groups as for macroscopic damage; only a nonsignificant reduction of damage was observed histologically in stomachs of rats assuming thermal water. In conclusion, these results indicate that chronic treatment of rats with thermal water, rich in sulphur compounds, may have only minimal effects on the rat gastric mucosa and did not significantly affect mucosal defense mechanisms. The observed tendency to gastroprotection would possibly need further investigation with longer periods of administration.


Subject(s)
Gastric Mucosa/drug effects , Mineral Waters , Sulfur Compounds/pharmacology , Animals , Body Weight , Cytoprotection , Dose-Response Relationship, Drug , Ethanol/toxicity , Gastric Acid/metabolism , Gastric Mucosa/metabolism , Gastric Mucosa/pathology , Histamine/metabolism , Indomethacin/toxicity , Male , Pentagastrin/metabolism , Rats , Rats, Wistar , Time Factors
8.
Regul Pept ; 160(1-3): 49-56, 2010 Feb 25.
Article in English | MEDLINE | ID: mdl-19945488

ABSTRACT

The 17-amino acid peptide nociceptin/orphanin FQ (N/OFQ) plays a role in the regulation of stress responses and of emotional disorders. The objective of this study is to evaluate whether long-term peripheral N/OFQ could dose- and time-dependently influence the responses to repeated cold-restraint stress on the rat gastric and colonic mucosa. Rats were exposed to cold-restraint stress for 3h per day for 1, 2 and 3 consecutive days. N/OFQ was administered at doses of 0.1, 1 and 10 microg/kg/h via Alzet osmotic minipumps. In the gastric fundus, N/OFQ exerted dose-dependent beneficial effects against acute and repeated stress but, after prolonged treatment, became damaging in non-stressed rats. In the distal colon, N/OFQ exerted a protective effect against damage by acute and repeated stress with no influence on epithelial integrity in non-stressed rats. In both regions, the peptide itself dose- and time-dependently reduced intraepithelial mucins. The reduction in mucin content caused by stress was effectively counteracted by N/OFQ, 0.1 microg/kg/h, in the distal colon only. N/OFQ did not modify basal mucosal cell proliferation. The peptide at 0.1 and 1 microg/kg/h had no influence while at 10 microg/kg/h abolished stress-induced increase in cell proliferation. The present results provide evidence that N/OFQ is implicated in the regulation of resting and stress-challenged mucosal integrity and activity of mucin-producing cells.


Subject(s)
Colon/drug effects , Gastric Mucosa/drug effects , Intestinal Mucosa/drug effects , Opioid Peptides/pharmacology , Stress, Physiological/drug effects , Vasodilator Agents/pharmacology , Animals , Food Deprivation , Immunohistochemistry , Injections, Intramuscular , Injections, Subcutaneous , Male , Microscopy, Electron, Scanning , Rats , Rats, Wistar , Nociceptin
9.
Regul Pept ; 154(1-3): 32-8, 2009 Apr 10.
Article in English | MEDLINE | ID: mdl-19046996

ABSTRACT

The participation of hypothalamus-pituitary-adrenal axis in the gastroprotective effects of nociceptin/orphanin FQ (N/OFQ) has been investigated. Gastric mucosal lesions were induced by intragastric administration of 50% ethanol, 1 ml/rat. Rats received N/OFQ either by the intracerebroventricular (icv) route, at 3 microg/rat, or by the intraperitoneal (ip) route, at 10 microg/kg, 30 min before ethanol administration. The protective effect of icv and ip administered N/OFQ was assessed in adrenalectomized rats and in rats pretreated with the glucocorticoid receptor antagonist, mifepristone, or with the CRF receptor antagonist, alpha-helical CRF(9-41). The damaging effect of ethanol was apparently not influenced by adrenalectomy. N/OFQ markedly reduced macroscopically and histologically assessed gastric mucosal damage. The extent of reduction by N/OFQ was comparable in adrenalectomized and in sham-operated rats, with either icv or ip route of administration. Pretreatment with mifepristone, both icv (80 microg/rat) and ip (10 mg/kg) injected, did not modify the response to icv and ip N/OFQ. Pretreatment with alpha-helical CRF(9-41) (25 microg/rat icv or 250 microg/kg ip), had no effect on the reduction of gastric damage produced by icv or ip N/OFQ. Present findings suggest that the gastroprotective effects of N/OFQ on ethanol-induced damage do not involve the endocrine pathway through the HPA axis.


Subject(s)
Hypothalamo-Hypophyseal System/metabolism , Opioid Peptides/pharmacology , Pituitary-Adrenal System/metabolism , Stomach Diseases/pathology , Stomach Diseases/prevention & control , Adrenalectomy , Animals , Corticotropin-Releasing Hormone/antagonists & inhibitors , Dose-Response Relationship, Drug , Ethanol/toxicity , Gastric Mucosa/drug effects , Gastric Mucosa/pathology , Injections, Intraperitoneal , Injections, Intraventricular , Male , Mifepristone/administration & dosage , Opioid Peptides/administration & dosage , Peptide Fragments/antagonists & inhibitors , Rats , Rats, Wistar , Receptors, Glucocorticoid/antagonists & inhibitors , Stomach Diseases/chemically induced , Time Factors , Nociceptin
10.
Peptides ; 30(4): 727-34, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19070636

ABSTRACT

In previous work, we observed that N/OFQ-induced hyperphagia is greater in DA rats, animals resistant to metabolic syndrome, than in WOKW animals, which are prone to this disease. We attributed this difference to the fact that these two strains have different Cart gene sequences and expression. As a preliminary approach to pursue this hypothesis, the present work focused on Cart gene expression by developing from DA and WOKW rats various congenic animals with exchanges of metabolic syndrome-related QTL's of different chromosomes (3, 5, 10 and 16), and analyzing their N/OFQ-induced (2.1, 4.2, and 8.4nmol/rat) food intake in terms of their CART gene expression and N/OFQ hypothalamic immunostaining. Two groupings emerged, the first, with strains 3a, 3b, and 5a with elevated N/OFQ-induced feeding similar to that of the DA rats, and the second, with strains 16 and 10, with lower feeding, like the WOKW rats. There was a perfect correlation between Cart gene expression and N/OFQ-induced feeding data at 30min for the strains DA, 3a, 3b, 5 in the first group, and 16 and WOKW for the second, but not for strain 10. As expected, the strains with low content of Cart gene expression had elevated N/OFQ-induced feeding, but contrary to expectations, strain 10, with the lowest Cart gene expression, exhibited low N/OFQ-induced feeding, on the order of that of the WOKW rats. A comparable trend was observed with N/OFQ hypothalamic immunostaining. This anomaly may be due to other satiety-related factors involved in N/OFQ-induced feeding.


Subject(s)
Feeding Behavior/drug effects , Gene Expression Regulation/drug effects , Metabolic Syndrome/genetics , Nerve Tissue Proteins/genetics , Opioid Peptides/pharmacology , RNA, Messenger/genetics , Animals , Genetic Predisposition to Disease , Immunohistochemistry , Rats , Species Specificity , Nociceptin
11.
Histol Histopathol ; 23(7): 789-98, 2008 07.
Article in English | MEDLINE | ID: mdl-18437677

ABSTRACT

The histamine H3 receptor (H3R) has been identified in the gastrointestinal tract of the rat by immunohistochemistry, using the first validated anti-H3 receptor antibody. Immunoreactivity to H3R was exclusively localized to the endocrine cells scattered in the gastrointestinal mucosa, with positive cells being prominently abundant in the gastric fundus, while they were rarely found in the other regions. In the fundus, positive cells were distributed in the lower half of the mucosa and their number significantly decreased after a 24 h-fasting period. Double-labeling studies were undertaken to identify the H3R-immunoreactive cell types in the fundic and antral mucosa. The H3R-immunoreactive cells were positive for chromogranin A. In the fundus, approximately 90% of cells positive to H3R were also positive to the histamine-forming enzyme, histidine decarboxylase. None of the cells expressing H3R displayed immunoreactivity for gastrin, somatostatin or ghrelin. Location, the influence of food deprivation and colocalization with histidine decarboxylase indicate that H3R positive cells correspond to the enterochromaffin-like cells (ECL).


Subject(s)
Enterochromaffin Cells/metabolism , Gastric Mucosa/metabolism , Lower Gastrointestinal Tract/metabolism , Receptors, Histamine H3/metabolism , Upper Gastrointestinal Tract/metabolism , Animals , Biomarkers/metabolism , Enterochromaffin Cells/cytology , Fluorescent Antibody Technique, Indirect , Food Deprivation/physiology , Gastric Mucosa/cytology , Histidine Decarboxylase/metabolism , Lower Gastrointestinal Tract/cytology , Male , Rats , Rats, Wistar , Upper Gastrointestinal Tract/cytology
12.
Peptides ; 28(8): 1572-9, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17651865

ABSTRACT

The influence of peripheral nociceptin/orphanin FQ (N/OFQ) on cold restraint-induced gastric mucosal damage in the rat was investigated. Exposure to cold-restraint for 3 and 4h caused the formation of hemorrhagic lesions in the glandular portion of the stomach. N/OFQ dose-dependently decreased lesion formation, in the range 0.03-1 microg/kg/h i.p. Its effect was reversed by the selective NOP receptor antagonist [Nphe(1)Arg(14)Lys(15)]N/OFQ-NH(2) (UFP-101), 30 microg/kg/h ip. The selective NOP receptor agonist [(pF)Phe(4)Aib(7)Arg(14)Lys(15)]N/OFQ-NH(2) (UFP-112), 0.01-0.3 microg/kg/h i.p., similarly reduced lesion formation. Light and scanning electron microscopy confirmed the protective activity of N/OFQ. Cold-restraint stress causes a reduction in mucus content and in adhering mucus layer, partly counteracted by N/OFQ. These results suggest that N/OFQ counteracts acute stress-induced gastric mucosal damage by interacting with NOP receptor and by influencing mucous cell activity.


Subject(s)
Gastric Mucosa/drug effects , Opioid Peptides/pharmacology , Peptide Fragments/pharmacology , Animals , Cold Temperature/adverse effects , Gastric Mucosa/injuries , Gastric Mucosa/metabolism , Male , Microscopy, Electron, Scanning , Narcotic Antagonists , Opioid Peptides/administration & dosage , Opioid Peptides/metabolism , Peptide Fragments/administration & dosage , Peptide Fragments/metabolism , Rats , Rats, Wistar , Receptors, Opioid/metabolism , Restraint, Physical/adverse effects , Stress, Physiological/complications , Stress, Physiological/metabolism , Nociceptin Receptor
13.
Naunyn Schmiedebergs Arch Pharmacol ; 374(4): 283-91, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17151854

ABSTRACT

Proton pump inhibitors (PPIs) have been shown to be effective in preventing gastric and duodenal ulcers in high-risk patients taking nonsteroidal anti-inflammatory drugs (NSAIDs); by contrast, scarce information is available concerning the effects of PPIs on intestinal damage induced by NSAIDs in humans or in experimental animals. We examined the effects of lansoprazole and omeprazole on the intestinal injury induced by indomethacin in the conscious rat. PPIs were administered by the intragastric route at 30, 60 and 90 micromol/kg, 12 h and 30 min before and 6 h after indomethacin treatment. The effects of omeprazole and lansoprazole were evaluated on: (1) macroscopic and histologic damage; (2) mucosal polymorphonuclear cell infiltration; (3) oxidative tissue damage and (4) bacterial translocation from lumen into the intestinal mucosa. Lansoprazole and omeprazole (at 90 micromol/kg) significantly decreased (P<0.01) the macroscopic and histologic damage induced by indomethacin in the rat small intestine. Furthermore, both drugs greatly reduced (P<0.01) the associated increases in myeloperoxidase levels and lipid peroxidation induced by indomethacin, whereas they only moderately affected (P<0.05) the translocation of enterobacteria from lumen into the intestinal mucosa. These data demonstrate that omeprazole and lansoprazole can protect the small intestine from the damage induced by indomethacin in the conscious rat. The intestinal protection, possibly related to antioxidant and anti-inflammatory properties of these drugs, may suggest new therapeutic uses of PPIs in intestinal inflammatory diseases.


Subject(s)
Indomethacin/toxicity , Intestine, Small/drug effects , Proton Pump Inhibitors , 2-Pyridinylmethylsulfinylbenzimidazoles/pharmacology , Animals , Anti-Ulcer Agents/pharmacology , Bacteria, Aerobic/drug effects , Bacteria, Anaerobic/drug effects , Bacterial Translocation/drug effects , Dose-Response Relationship, Drug , Humans , Indomethacin/administration & dosage , Intestinal Mucosa/drug effects , Intestinal Mucosa/microbiology , Intestinal Mucosa/pathology , Intestine, Small/microbiology , Intestine, Small/pathology , Intubation, Gastrointestinal , Jejunum/drug effects , Jejunum/microbiology , Jejunum/pathology , Lansoprazole , Male , Malondialdehyde/metabolism , Neutrophil Infiltration/drug effects , Omeprazole/pharmacology , Oxidative Stress/drug effects , Peroxidase/metabolism , Rats , Rats, Wistar , Severity of Illness Index
14.
Eur J Pharmacol ; 552(1-3): 143-50, 2006 Dec 15.
Article in English | MEDLINE | ID: mdl-17069793

ABSTRACT

It is now widely recognized that nonsteroidal anti-inflammatory drugs (NSAIDs) may cause extensive damage to the intestine. The pathogenesis of NSAID-induced intestinal injury, however, is still controversial and both local irritant actions and cyclooxygenase (COX) inhibition have been proposed as underlying mechanisms. In this study we investigated further on NSAID-induced intestinal damage by using nonselective (indomethacin and ibuprofen), COX-1 selective (SC-560) or COX-2 selective (celecoxib) inhibitors. NSAIDs were administered orally to conscious rats and small intestinal injury was evaluated 24 h afterwards in terms of macroscopic and microscopic alterations, myeloperoxidase activity, lipid peroxidation, number of enterobacteria in the mucosa and epithelial mucin content. Oral administration of indomethacin (20 mg/kg) induced macroscopic and microscopic damage to the small intestine, increased translocation of enterobacteria from lumen into the mucosa, myeloperoxidase activity and lipid peroxidation. Ibuprofen (120 mg/kg), SC-560 (20 mg/kg), celecoxib (60 mg/kg) or the combination of SC-560 plus celecoxib did not cause any intestinal injury nor modified the number of bacteria in mucosal homogenates. SC-560 significantly increased both myeloperoxidase activity and lipid peroxidation, whereas celecoxib significantly reduced myeloperoxidase levels, while leaving unaltered lipid peroxidation. Finally, all NSAIDs, mostly indomethacin, increased neutral mucins and decreased acidic mucins in the intestinal goblet cells. These results indicate that inhibition of cyclooxygenase, although variably influencing mucosal integrity homeostasis, is not sufficient to initiate acute intestinal damage in rats. Moreover, topical mucosal injury induced by the NSAID molecule seems to be a critical factor in the development of intestinal injury.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/toxicity , Cyclooxygenase Inhibitors/toxicity , Intestine, Small/drug effects , Administration, Oral , Analysis of Variance , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Celecoxib , Cyclooxygenase 1/metabolism , Cyclooxygenase 2/metabolism , Cyclooxygenase Inhibitors/administration & dosage , Enterobacteriaceae/cytology , Enterobacteriaceae/growth & development , Ibuprofen/administration & dosage , Ibuprofen/toxicity , Indomethacin/administration & dosage , Indomethacin/toxicity , Intestinal Mucosa/drug effects , Intestinal Mucosa/metabolism , Intestinal Mucosa/microbiology , Intestine, Small/metabolism , Intestine, Small/pathology , Lipid Peroxidation/drug effects , Male , Mucins/metabolism , Peroxidase/metabolism , Pyrazoles/administration & dosage , Pyrazoles/toxicity , Rats , Rats, Wistar , Sulfonamides/administration & dosage , Sulfonamides/toxicity
15.
Eur J Pharmacol ; 538(1-3): 141-7, 2006 May 24.
Article in English | MEDLINE | ID: mdl-16682020

ABSTRACT

The temporal effect of (R)-alpha-methylhistamine on epithelial cell proliferation throughout the rat gastrointestinal tract was investigated. (R)-alpha-methylhistamine was administered at 100 mg/kg orally and the rats were sacrificed 1, 24, 48, 72 and 144 h later. All the animals received 5-bromo-2'-deoxyuridine, (BrdU), 200 mg/kg i.p., 2 h before sacrifice. Gastrointestinal tissue was processed for histology and immunohistochemistry. (R)-alpha-methylhistamine caused a progressive increase in mucosal thickness of gastric fundus, distal small intestine and distal colon. Statistically significant differences from control values were found between 48 and 72 h after (R)-alpha-methylhistamine. (R)-alpha-methylhistamine significantly increased the number of BrdU-positive cells in the gastric fundus and antrum, intermediate and distal small intestine and distal colon. Peak effects were observed between 1 and 24 h after (R)-alpha-methylhistamine administration. Proliferating cell number and mucosal thickness were comparable to those of control rats at 144 h. (R)-alpha-methylhistamine exerts a long lasting growth-promoting effect on the stomach, distal small intestine and distal colon. Present data support a role of histamine H(3) receptors in the normal regulation of cell cycle in epithelial tissue.


Subject(s)
Cell Proliferation/drug effects , Epithelial Cells/drug effects , Gastrointestinal Tract/drug effects , Histamine Agonists/pharmacology , Methylhistamines/pharmacology , Analysis of Variance , Animals , Colon/cytology , Colon/drug effects , Epithelial Cells/cytology , Gastrointestinal Tract/cytology , Ileum/cytology , Ileum/drug effects , Intestinal Mucosa/cytology , Intestinal Mucosa/drug effects , Intestinal Mucosa/physiology , Male , Rats , Rats, Wistar , Receptors, Histamine H3/physiology , Stomach/cytology , Stomach/drug effects , Time Factors
16.
Endocrinology ; 146(9): 3861-7, 2005 Sep.
Article in English | MEDLINE | ID: mdl-15919744

ABSTRACT

Nociceptin (N/OFQ) exerts multiple effects in the gastrointestinal tract after central or peripheral administration. In the present study, we examined the possible peripheral mechanisms mediating gastric protection by N/OFQ in rats. Gastric mucosal lesions were induced by 50% ethanol (1 ml/rat intragastrically). N/OFQ, administered either intracerebroventricularly (3 microg/rat) or ip (10 microg/kg), significantly reduced macroscopic and histological damage. The protective effect of intracerebroventricular N/OFQ was blocked by atropine, subdiaphragmatic vagotomy, and bretylium. The effect of both central and peripheral N/OFQ was blocked by functional ablation of afferent nerves produced by capsaicin, by the antagonist of calcitonin gene-related peptide, CGRP(8-37), and by the nitric oxide synthase inhibitor, N(G)-nitro-L-arginine methyl ester. These results indicate that N/OFQ increases gastric mucosal resistance to ethanol by operating both in the central nervous system and in the periphery. Vagal cholinergic and sympathetic pathways mediate the central activity of N/OFQ, whereas vagal nonmuscarinic pathways mediate the peripheral activity of the peptide. The neuronal circuit involving extrinsic sensory neurons, calcitonin gene-related peptide, and nitric oxide is activated by central as well as peripheral N/OFQ. The study provides evidence that N/OFQ contributes to neurally mediated gastric mucosal protection.


Subject(s)
Gastric Mucosa/drug effects , Gastric Mucosa/physiology , Opioid Peptides/pharmacology , Animals , Anti-Arrhythmia Agents/pharmacology , Atropine/pharmacology , Bretylium Compounds/pharmacology , Calcitonin Gene-Related Peptide/pharmacology , Central Nervous System Depressants/pharmacology , Ethanol/pharmacology , Ganglionic Blockers/pharmacology , Gastric Mucosa/innervation , Hexamethonium/pharmacology , Injections, Intraperitoneal , Injections, Intraventricular , Male , Miotics/pharmacology , Neurons, Afferent/drug effects , Neurons, Afferent/physiology , Nitric Oxide/metabolism , Parasympathetic Nervous System/cytology , Parasympathetic Nervous System/physiology , Parasympatholytics/pharmacology , Peptide Fragments/pharmacology , Rats , Rats, Wistar , Sympathetic Nervous System/cytology , Sympathetic Nervous System/physiology , Vagotomy , Nociceptin
17.
Pharmacology ; 74(3): 135-42, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15756055

ABSTRACT

Bacterial antigens, such as intestinal microflora, are known to play a role in the pathogenesis of human inflammatory bowel disease (IBD). Tylosin, a macrolide antimicrobial agent, has proven to be effective in cat and dog chronic colitis, but the reasons underlying this efficacy are still unclear. In the present study we evaluated the effects of tylosin on 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis in the rat, in comparison with the antibacterial drug metronidazole and the corticosteroid budesonide. Colitis was induced by a single intrarectal administration of 10 mg TNBS under light ether anesthesia. Tylosin (20 mg/kg twice a day), metronidazole (160 mg/kg twice a day) and budesonide (500 microg/kg once a day) were given orally for up to 6 days to separate groups of rats. The animals were sacrificed after 6 days and colonic lesions evaluated (colon weight, macroscopic and histologic damage, myeloperoxidase activity). Tylosin and metronidazole significantly lowered macroscopic lesion score, reduced colon weight, the severity of histologic lesions and myeloperoxidase activity; budesonide did not significantly change the parameters of colonic inflammation. These data indicate a protective effect of tylosin against intestinal inflammation, suggesting a major role for bacteria, anaerobes in particular, in the development of TNBS-induced mucosal damage.


Subject(s)
Anti-Bacterial Agents/pharmacology , Colitis/drug therapy , Trinitrobenzenesulfonic Acid , Tylosin/pharmacology , Animals , Anti-Inflammatory Agents/pharmacology , Budesonide/pharmacology , Colitis/chemically induced , Colitis/pathology , Colon/drug effects , Colon/enzymology , Colon/pathology , Disease Models, Animal , Male , Metronidazole/pharmacology , Peroxidase/biosynthesis , Rats , Rats, Wistar
18.
Digestion ; 68(2-3): 124-32, 2003.
Article in English | MEDLINE | ID: mdl-14610345

ABSTRACT

BACKGROUND/AIMS: The compound amtolmetin guacyl (AMG) has been characterized in both animal and human studies as a novel non-selective non-steroidal anti-inflammatory drug (NSAID) endowed with lower ulcerogenicity in comparison with traditional NSAIDs due to a unique mechanism of action, namely the increase in endogenous production of gastric nitric oxide. METHODS: Conscious rats were treated either acutely (4 h) or chronically (3 and 14 days) with intragastric AMG (50 and 150 mg/kg), the non-selective NSAID tolmetin (TOL, 30 and 100 mg/kg) or the COX-2-selective NSAID celecoxib (CXIB, 20 and 60 mg/kg). Macroscopically visible and histologic lesions were evaluated. The ultrastructure of mucosal microvasculature was assessed. RESULTS: (1) TOL and CXIB caused quantitatively greater endothelial damage and inflammatory cell infiltration than that induced by AMG; (2) AMG and CXIB, unlike TOL, did not cause epithelial damage after acute or chronic treatment, and (3) gastric lesions induced by TOL underwent adaptation during chronic treatment. CONCLUSION: Endothelial cell damage in the gastric microvasculature is an early event following both non-selective and COX-2-selective inhibitors. The low gastric mucosal toxicity of AMG is confirmed after acute and chronic treatment.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/toxicity , Cyclooxygenase Inhibitors/toxicity , Gastric Mucosa/drug effects , Glycine/analogs & derivatives , Glycine/toxicity , Pyrroles/toxicity , Analysis of Variance , Animals , Male , Microscopy, Electron , Rats , Rats, Wistar
19.
Br J Pharmacol ; 137(2): 237-44, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12208781

ABSTRACT

1. (R)-alpha-methylhistamine, a selective agonist of histamine H(3) receptors, promotes mucus secretion and increases the number and volume of mucus-secreting cells. The hypothesis that the increased number of mucous cells could reside in an alteration of homeostasis in the gastric epithelium was investigated. 2. (R)-alpha-methylhistamine was administered to rats 1 h (10-100 mg kg(-1) by intragastric and by intraperitoneal route) and 24 h (100 mg kg(-1) by intragastric route) prior to killing. The (S)-isomer of alpha-methylhistamine (55.4 mg kg(-1)), 100 times less potent than the (R)-isomer at H(3) receptors, and the H(3)-receptor agonist FUB 407 (9.14-91.35 mg kg(-1)) were intragrastically administered 1 h prior to killing. The H(1)-receptor antagonist mepyramine (30 mg kg(-1)), the H(2)-receptor antagonist famotidine (3 mg kg(-1)), and the H(3)-receptor antagonists ciproxifan (3 mg kg(-1)) and clobenpropit (30 mg kg(-1)) were intragastrically administered 30 min before (R)-alpha-methylhistamine. Gastric tissue was processed for histology and immunohistochemistry. 3. Within 1 h, (R)-alpha-methylhistamine and FUB 407 dose-dependently increased the number of BrdU-positive cells and of apoptotic cells. (S)-alpha-methylhistamine failed to modify proliferation and apoptosis. The increase in proliferation by (R)-alpha-methylhistamine was reversed by ciproxifan and clobenpropit, but not by mepyramine and famotidine. 4. (R)-alpha-methylhistamine accelerated the differentiation towards pit cells and their outward migration 24 h after its administration. These effects were counteracted by ciproxifan. The apoptosis rate was unaffected at 24 h. 5. These findings reveal a primary role of histamine H(3)-receptor ligands in modulating cell proliferation and migration in rat fundic mucosa.


Subject(s)
Gastric Mucosa/drug effects , Histamine Agonists/pharmacology , Methylhistamines/pharmacology , Receptors, Histamine H3/drug effects , Animals , Apoptosis/drug effects , Cell Division/drug effects , Cell Movement/drug effects , Dose-Response Relationship, Drug , Gastric Mucosa/pathology , Ligands , Male , Rats , Rats, Wistar , Receptors, Histamine H3/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...